Text ::   Skip Nav ::

circare logo


Brochure Contact Home Privacy Site Map Terms of Use Tools

print Print Page ::   Link to CIRCARE Link To ::

Index of Documents Related to Henry Heimlich M.D.

This page links to FOIA documents related to induced malaria research proposed or sponsored by Henry Heimlich M.D. and The Heimlich Institute Foundation Inc. Follow this link to the full discussion of induced malaria for HIV/AIDS

Follow this link for information and discussion about documents released by UCLA regarding induced malaria for HIV/AIDS

Follow this link to find an index of the documents released by UCLA regarding induced malaria for HIV/AIDS

Induced Malaria Therapy (IMT) As Proposed by Henry J. Heimlich M.D. and The Heimlich Institute Foundation Inc.

IMT A Potential Cure for AIDS Funding Proposal

IMT: A Potential Cure For AIDS A Proposal For Funding by The Heimlich Institute Foundation Inc. 1993: http://www.circare.org/foia2/hh_imt_proposal.pdf

Petition for Federal Investigation of Proposed IMT Study for HIV/AIDS

Bronston, PK. Petition to U.S. Federal Agencies, Public Citizen, and The National Council Against Health Fraud to investigate issues raised by IMT: A Potential Cure For AIDS, funding proposal circulated by the Heimlich Institute. 1993-05-07: http://www.circare.org/foia2/imtpetition.pdf

Expert Opinions on Proposed IMT Study (IMT for HIV/AIDS) Accompanying Petition

del Rio C. Letter to Paul Bronston, M.D. 1993-03-12: http://www.circare.org/foia2/delrio_bronston_19930312.pdf

del Rio C. Letter to Lisa Wilson, The Pasadena Star-Tribune. 1993-05-04: http://www.circare.org/foia2/delrio_wilson_19930504.pdf

del Rio C. Letter to Paul Bronston, M.D. 1993-11-16: http://www.circare.org/foia2/delrio_bronston_19941116.pdf

Sonnenberg FA. Letter to Paul Bronston, M.D. 1993-03-10: http://www.circare.org/foia2/sonnenberg_bronston_19930310.pdf

Sigal LH. Letter to Paul Bronston, M.D. 1993-03-15: http://www.circare.org/foia2/sigel_bronston_19930315.pdf

Mitsuyasu RT. Letter to Paul Bronston, M.D. 1993-03-15: http://www.circare.org/foia2/mitsuyasu_bronston_19930315.pdf

Dominguez EA. Letter to Paul Bronston, M.D. 1993-03-10: http://www.circare.org/foia2/dominguez_bronston_19930310.pdf

Oliver A. Letter to Paul Bronston, M.D. 1993-03-16: http://www.circare.org/foia2/oliver_bronston_19930316.pdf

Lanzer M. Letter to Paul Bronston, M.D. 1993-03-15: http://www.circare.org/foia2/lanzer_bronston_19930315.pdf

U.S. Centers for Disease Control (CDC) Position on Induced Malaria Therapy (IMT) for HIV/AIDS

U.S. Centers for Disease Control. Comments for the Record re: IMT (induced malariatherapy): A Potential Cure for AIDS. 1993-04-29: http://www.bioethicswatch.org/foia/cdc_hh_19930429.pdf

top

Clinical Trial Documents: Induced Malaria Therapy (IMT) for HIV/AIDS

Protocol, Induced Malaria Therapy (IMT) for HIV/AIDS

Heimich H. and The Heimlich Institute Foundation Inc. Protocol: A Pilot Study of Induced Malaria Therapy in 30 Human Immunodeficiency Virus Positive Individuals. 1993-09-01: http://www.circare.org/foia2/malarioth_protocol.pdf

Informed Consent: Induced Malaria Therapy (IMT) for HIV/AIDS

Heimich H. and The Heimlich Institute Foundation Inc. Consent Form: Induced Malaria as Therapy for HIV Infection. 1993-09-01: http://www.circare.org/foia2/imtconsentform_19931029.pdf

IRB Review and Approval of Induced Malaria Therapy (IMT) for HIV/AIDS

Chappell LT. Letter of approval by the Great Lakes Association of Clinical Medicine Institutional Review Board to H. Heimlich, M.D. for Induced Malaria study. 1994-05-27: http://www.circare.org/foia2/glccm_hh19940527.pdf

Heimich H. Letter to L. T. Chappell M.D. and the Great Lakes Association of Clinical Medicine Institutional Review Board re: FDA restrictions on the IRB and status of clinical trial titled Heimlich Maneuver for Asthma. 2000-04-25: http://www.bioethicswatch.org/foia/hh_ltc_20000425.pdf

Heimich H. Letter to J. Henney M.D., Commissioner, U.S. Food and Drug Administration. 2000-05-04: http://www.circare.org/foia2/hh_fda20000504.pdf
Enclosure: http://www.circare.org/foia2/hh_fda20000504encl.pdf

Masiello S. Letter to H. Heimlich M.D., on behalf of J. Henney M.D., Commissioner, U.S. Food and Drug Administration. 2000-06-08: http://www.circare.org/foia2/fda_hh20000608.pdf

Follow this link for more information about Dr. Heimlich's research testing Induced Malaria in subjects diagnosed with HIV/AIDS: http://www.circare.org/malariotherapy.htm

top

Correspondence: U.S. Centers for Disease Control (CDC), Dr. Heimlich, and Induced Malaria Therapy (IMT) for Cancer

Kaiser RL. Letter to Henry Heimlich M.D., re: malariatherapy for cancer. 1986-09-09: http://www.bioethicswatch.org/foia/cdc_hh19860909.pdf

Kaiser RL. Letter to Henry Heimlich M.D., re: malariatherapy for cancer. 1986-10-15: http://www.bioethicswatch.org/foia/cdc_hh19861015.pdf

Kaiser RL. Letter to Henry Heimlich M.D., re: malariatherapy for cancer. 1987-04-10: http://www.bioethicswatch.org/foia/cdc_hh19870410.pdf

Kaiser RL. Letter to Henry Heimlich M.D., re: malariatherapy for cancer. 1987-05-29: http://www.bioethicswatch.org/foia/cdc_hh19870529.pdf

Heimlich H. Letter to Robert L. Kaiser M.D. re: update on malariatherapy for cancer. 1987-07-22: http://www.bioethicswatch.org/foia/hh_cdc19870722.pdf

Heimlich H. Letter to James O. Mason, M.D. MPH re: media responses by CDC on malariatherapy for cancer. 1988-03-07: http://www.bioethicswatch.org/foia/hh_cdc19880307.pdf

Heimlich H. Letter to Robert L. Kaiser M.D. re: update on malariatherapy for cancer. 1988-12-02: http://www.bioethicswatch.org/foia/hh_cdc19881202.pdf

top

Correspondence: U.S. Centers for Disease Control (CDC), Dr. Heimlich, and Induced Malaria Therapy (IMT) for Lyme Disease

Dennis DT, Campbell CC. Memo re: malariatherapy for Lyme disease. 1990-01-19: http://www.bioethicswatch.org/foia/cdc_ste19900119.pdf

Heimlich H. Letter to William L. Roper M.D. MPH re: CDC statements in MMWR Weekly for December 7, 1990 on induced malaria for Lyme disease. 1990-12-31: http://www.bioethicswatch.org/foia/hh_cdc19901231.pdf

EIS Officer Malaria Branch. Centers for Disease Control. Memo re: malariatherapy for Lyme disease. 1991-01-14: http://www.bioethicswatch.org/foia/cdc19910114.pdf

Heimlich H. Letter to William L. Roper M.D. MPH re: CDC memo of 1990-01-19. 1991-04-24: http://www.bioethicswatch.org/foia/hh_cdc19910424.pdf

Roper WL. Letter to Henry Heimlich M.D. re: refusal of retraction of CDC statements in MMWR Weekly for December 7, 1990 on induced malaria for Lyme disease. 1991-06-18: http://www.bioethicswatch.org/foia/cdc_hh19910618.pdf

Heimlich H. Letter to William L. Roper M.D. MPH. 1991-06-27: http://www.bioethicswatch.org/foia/hh_cdc19910627.pdf

Heimlich H. Letter to William L. Roper M.D. MPH. 1991-09-04: http://www.bioethicswatch.org/foia/hh_cdc19910904.pdf

Heimlich H. Letter to James O. Mason, M.D. MPH re: CDC position on malariatherapy for Lyme Disease. 1991-11-27: http://www.bioethicswatch.org/foia/hh_cdc19911127.pdf
Enclosure, Documentation of Misrepresentation by Centers for Disease Control (CDC): http://www.bioethicswatch.org/foia/hh_cdc19911127appndx.pdf

AHA Special Situations Committee Correspondence (1985)

Dr. Heimlich was appointed to serve on the Special Situations Committee at the American Heart Association (AHA) National Conference on Standards for Cardiopulmonary Resuscitation and Emergency Cardiac Care in July, 1985. The committee was charged, in part, to evaluate and recommend procedures for first responders (e.g., paramedics) in accidents involving near-drowning. Dr. Heimlich proposed that the Heimlich Manoeuver be adopted as an initial procedure in cases of near-drowning. Dr. Heimlich provided the committee with no credible published data to support the use of the Heimlich Manoeuver in cases of near-drowning. When the committee declined to recommend his maneuver in preference to rescue breathing and external chest compression (e.g., mouth-to-mouth / CPR), Dr. Heimlich sent a series of increasingly vitrolic letters to committee chair Joseph Ornato M.D. At the same time Dr. Heimlich filed charges of academic misconduct against Dr. Ornato with Virginia Commonwealth University, perhaps in an attempt to intimidate him. The charges were dismissed by the university and Dr. Ornato went on to a career that can only be called stellar. Among other things, in 2004 he published the results of the Public Access to Defibrillators Trial (the PAD trial). (1) This trial helped demonstrate the potential for benefit from emergency research with waiver of informed consent.

Today Dr. Ornato is Professor and Chairman, Department of Emergency Medicine at Virginia Commonwealth University: http://www.vcu.edu/mcved/iframe/staff/ornato.htm

Heimlich HJ. Letter to Joseph Ornato M.D. 1985-08-19: http://www.circare.org/foia2/heimlichornato_19850819.pdf

Ornato JP. Letter to Henry Heimlich M.D. 1985-08-23: http://www.circare.org/foia2/ornatoheimlich_19850823.pdf

Heimlich HJ. Letter to Joseph Ornato M.D. 1985-09-24: http://www.circare.org/foia2/heimlichornato_19850924.pdf

Ornato JP. Letter to Henry Heimlich M.D. 1985-11-11: http://www.circare.org/foia2/ornatoheimlich_19851111.pdf

Heimlich HJ. Letter to Joseph Ornato M.D. 1985-11-20: http://www.circare.org/foia2/heimlichornato_19851120.pdf

Patrick EA. Letter to Joseph Ornato M.D. 1985-09-04: http://www.circare.org/foia2/patrickornato_19850904.pdf

Steinman AM. Letter to Joseph Ornato M.D. 1985-10-12: http://www.circare.org/foia2/steinmanornato_19851012.pdf

Moddell JH. Letter to Joseph Ornato M.D. 1985-10-18: http://www.circare.org/foia2/moddellornato_19851018.pdf

Nemiroff MJ. Letter to Joseph Ornato M.D. 1985-10-18: http://www.circare.org/foia2/nemiroffornato_19851018.pdf

Dail CP. Letter to Joseph Ornato M.D. 1985-10-25: http://www.circare.org/foia2/dailornato_19851025.pdf


top

Notes

Ornato JP, for the PAD Trial Investigators. The Public Access Defibrillation (PAD) Trial study design and rationale. Resuscitation. 2003;56:135-147. Accessed on 2007-04-13 at: http://www.fda.gov/ohrms/dockets/dockets/95s0158/95s-0158-rpt0011-02.pdf

Last Updated: 2007-04-13

If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page


All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education.   Adobe® Reader ::   ::

Valid HTML 4.01! Valid CSS!